Resultado da Busca
Linda Avey, Paul Cusenza and Anne Wojcicki founded 23andMe in 2006 to offer genetic testing and interpretation to individuals. Investment documents from 2007 also suggest that 23andMe hoped to develop a database to pursue research efforts.
A former Wall Street analyst, Wojcicki teamed up with cofounder Linda Avey and Paul Cusenza to start 23andMe in 2006. 23andMe got a $300 million investment from GSK, formerly GlaxoSmithKline, in ...
Humain Ventures. Linda Avey is a founding Managing Partner of Humain Ventures, investing at the intersection of AI and life sciences.. She was at the forefront of the digital health movement as a founder of 23andMe and the first independent board director of Rock Health. Her interests span precision health, AI-driven drug development, and the ...
Linda Avey has over 20 years of sales and business development experience in the biopharmaceutical industry in San Francisco, Boston, San Diego, and Washington, D.C. Prior to starting 23andMe, she
Linda Avey is the co-founder and CEO of Austin-based Precisely (precise.ly), a digital assistant for automating routine medical flows and implementing personalized, value-based care. In 2006 Linda envisioned and co-founded 23andMe, the leading consumer genetics research company (NASDAQ: ME).
9 de mar. de 2024 · Linda Avey is a founding general partner at Humain Ventures, an Austin, TX-based venture capital firm investing at the intersection of AI and the bioeconomy. Linda has been at the forefront of the digital health movement. As the visionary founder of 23andMe, the company assembled a research repository of genetic and phenotypic data to study ...
